PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.\', \'Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Immunology and Cell Therapy Unit, Careggi University Hospital, Florence, Italy.\', \'Department of Emergency Radiology, Careggi University Hospital, Florence, Italy.\', \'Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Flow Cytometry Diagnostic Center and Immunotherapy (CDCI), Careggi University Hospital, Florence, Italy.\', \'Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Pneumology and Intensive Care Unit, Careggi University Hospital, Florence, Italy.\', \'Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Immunology and Cell Therapy Unit, Careggi University Hospital, Florence, Italy. Electronic address: lorenzo.cosmi@unifi.it.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0165-2478(20)30405-310.1016/j.imlet.2020.10.009
?:doi
?:hasPublicationType
?:journal
  • Immunology letters
is ?:pmid of
?:pmid
?:pmid
  • 33161002
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.168
?:rankingScore_hIndex
  • 81
is ?:relation_isRelatedTo_publication of
?:title
  • Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all